CJC-1295/Ipamorelin is a combination peptide therapy that works by signaling your body to naturally release its own growth hormone (GH), rather than providing synthetic hormone from the outside.
- CJC-1295 is a growth hormone–releasing hormone (GHRH) analog
- Ipamorelin is a growth hormone–releasing peptide (GHRP)
Together, they are used to support:
- Recovery from training and day-to-day physical stress
- Lean body mass and body-composition goals
- Sleep quality and overall sense of restoration
This is a prescription therapy available only after a full virtual evaluation with a Wellcore provider. It is not a body-building drug, steroid, or quick fix—it’s designed to be one tool in a broader, performance- and longevity-focused program.
Important Note: Compounded CJC-1295/Ipamorelin is prepared by licensed U.S. compounding pharmacies and is not reviewed or approved by the FDA. Your Wellcore provider will determine if this therapy is appropriate for you based on your medical history, goals, and current guidelines.
CJC-1295/Ipamorelin works upstream—by stimulating your own pituitary gland to release growth hormone in a more physiologic pattern.
CJC-1295 (GHRH analog):
- Mimics the action of your body’s natural growth hormone–releasing hormone
- Supports a more sustained release of GH over time
- Helps reinforce your body’s underlying GH signaling
Ipamorelin (GHRP):
- Acts on ghrelin receptors to trigger growth hormone pulses
- Tends to create sharp, controlled GH releases
- Pairs synergistically with CJC-1295 for a more robust GH signal
Why it matters:
- Growth hormone influences recovery, body composition, connective tissue integrity, and sleep quality
- By aiming to enhance your own GH rhythm, this combo is engineered to support strength and performance goals while aligning with a broader longevity strategy
Your Wellcore provider will tailor your protocol, including timing and frequency, to work alongside your training, nutrition, and recovery plan.
CJC-1295/Ipamorelin is most powerful when it’s not just “a vial on your counter,” but part of an integrated performance and longevity approach.
Performance & recovery–oriented design
- Supports post-training recovery, connective tissue resilience, and lean body mass goals
- Fits naturally into evening and sleep routines, when your body is wired to release more GH
- Aligns with strength, performance, and longevity stacks (e.g., NAD+, BPC-157, testosterone optimization when appropriate)
Clinician-guided, at-home therapy
- Prescribed only after a comprehensive telehealth evaluation
- Personalized protocol for dose, timing, and duration
- At-home, subcutaneous injections—no routine in-office visits required
Quality and transparency
- Compounded by U.S.-licensed 503A compounding pharmacies, where permitted
- Integrated safety screening, including medical history and medication review
- Ongoing access to Wellcore’s clinical support team for questions and adjustments
CJC-1295/Ipamorelin is designed for men focused on performance, recovery, and healthy aging, not just aesthetics.
You may be a good candidate if you:
- Train regularly (strength, conditioning, endurance, or mixed modalities)
- Want support for recovery, sleep quality, and lean body mass goals
- Are interested in longevity and performance markers, not just short-term “bulk”
- Prefer to stimulate your own GH release instead of using exogenous hormone
- Are willing to follow a structured protocol and maintain healthy lifestyle habits
It may not be right for you if you:
- Are looking for a shortcut without investing in training, nutrition, and sleep
- Have health conditions that make GH-modulating therapies unsafe
- Are seeking supraphysiologic, body-building–style use (this is not the intent of the program)
Final eligibility is always determined by a Wellcore provider after a full evaluation, including a review of your medical history and current medications.
Your exact protocol will be customized by your provider, but typical guidance may include:
- Route: Subcutaneous injection (just under the skin), commonly in the abdomen or thigh
- Timing: Often taken in the evening, away from meals, to align with natural GH release
- Frequency: Used on a regular schedule (for example, nightly or several nights per week) as directed
- Consistency: Take doses at roughly the same times and on the same days, as recommended
- Site rotation: Rotate injection sites to minimize local irritation
You’ll receive:
- Clear written instructions with your shipment
- Support from the Wellcore team if you have questions about technique, timing, or how to integrate the protocol with training and recovery
Never adjust your dose or schedule on your own; always consult your provider first.
Complete Treatment Package
- Multi-dose vial(s) of compounded CJC-1295/Ipamorelin at your prescribed concentration
- Appropriate syringes and injection needles
- Alcohol swabs and basic injection supplies
- Easy-to-follow instructions for storage, mixing (if applicable), and self-administration
- Cold-packed, discreet delivery shipped directly to your home where permitted
- Access to the Wellcore clinical support team for guidance, side-effect questions, and protocol refinements
Kit details may vary slightly depending on your prescription and partner pharmacy.
Your Treatment Journey
Start Your Online Evaluation
Get approved by provider
Receive Your product at Home
Start treatment with provider guidance
Is this the same as taking growth hormone (GH)?
No. CJC-1295/Ipamorelin does not provide synthetic GH. Instead, it is designed to signal your pituitary gland to release more of your body’s own growth hormone in a pattern that more closely resembles physiological pulses. It’s a GH-releasing strategy, not straight hormone replacement.
Will this make me “bulk up”?
This therapy is not a steroid or body-building drug. Many people use it to support recovery, lean mass, and body composition as part of a structured training and nutrition plan. How your body responds depends on your genetics, lifestyle, training style, and overall program design. Your provider’s focus is healthy, sustainable adaptation, not extreme or unnatural changes.
How long before I notice results?
Experiences vary. Some people report improvements in sleep quality, recovery, and general well-being within a few weeks. Shifts in body composition and performance trends typically evolve over weeks to months, especially when paired with consistent training, nutrition, and recovery habits.
Can I combine this with other peptides or hormone optimization?
Often, yes—if done under proper medical supervision. CJC-1295/Ipamorelin is commonly integrated into strength & performance and longevity stacks that may include testosterone optimization (when clinically indicated), NAD+ programs, BPC-157, or other peptides. Always disclose your full regimen so your provider can design a safe, coherent protocol.
Is CJC-1295/Ipamorelin FDA-approved?
Compounded CJC-1295/Ipamorelin formulations are not reviewed or approved by the FDA. They are prepared by licensed U.S. compounding pharmacies for individual patients under a provider’s prescription. Your provider will discuss FDA-approved alternatives and help you understand where this therapy fits within current standards and evidence.
Do Not Use This Medication If You:
- Have a history of active or recent cancer unless cleared by your oncology and endocrine teams
- Have been advised that growth hormone–modulating therapies are unsafe for you
- Are pregnant, planning to become pregnant, or breastfeeding
- Are known to be allergic to any component of the formulation
Use With Caution If You:
- Have significant cardiovascular disease, uncontrolled hypertension, or advanced heart failure
- Have diabetes or significant insulin resistance (your provider will evaluate and monitor this)
- Have significant liver or kidney impairment
- Have a history of carpal tunnel symptoms, edema, or sleep apnea, which may be worsened by GH-related therapies
Always share your full medical history and medication/supplement list with your provider before starting therapy.
Possible Side Effects May Include:
- Mild injection-site redness, irritation, or tenderness
- Transient flushing or warmth
- Mild water retention or puffiness
- Headache or lightheadedness
- Changes in sleep patterns (often improved, but occasionally disrupted for some)
Side effects are often dose- and schedule-dependent. If you notice persistent or concerning symptoms, contact your provider. Seek immediate medical attention if you experience signs of allergic reaction (such as hives, facial swelling, or difficulty breathing) or any severe or rapidly worsening symptom.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information on this page is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.
Important Information About Compounded CJC-1295/Ipamorelin
- Compounded medications are not reviewed or approved by the FDA and do not undergo the same pre-market evaluation as FDA-approved drugs.
- Wellcore’s compounded CJC-1295/Ipamorelin is prepared using peptide ingredients by FDA-registered, U.S.-licensed 503A compounding pharmacies, where available and clinically appropriate.
- Availability and formulation may vary based on state regulations, evolving clinical guidance, and pharmacy partners.
Wellcore does not practice medicine or provide direct medical care. All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product representations are for illustration only; actual packaging and supplies may differ.
*If you are interested in a prescription product, Wellcore will coordinate a telehealth visit with a licensed medical provider who will determine whether you are an appropriate candidate based on your health profile and current standards of care. If approved, a prescription will be issued and filled by one of our partner pharmacies unless you request a different pharmacy. All prescriptions are subject to provider discretion and clinical appropriateness.
